Found 6117 clinical trials
Pelle-926-203 Study, a research study for adults 18 years of age and older with High Frequency Basal Cell Carcinoma.
years of age and older at the time of study enrollment. The study comprises three periods: screening, treatment, and follow-up. Participation in this study will last approximately 10.5 months
- 129 views
- 23 Nov, 2020
- 3 locations
Endometriosis
drug). This study will assess the dysmenorrhea (painful periods) response in participants with endometriosis and associated pain.
- 0 views
- 27 Jun, 2022
- 1 location
Alpha-1 Study: A research study for individuals with Alpha-1 Antitrypsin Deficiency
the safety, tolerability, and effectiveness of an investigational medication in individuals with Alpha-1 Antitrypsin Deficiency. Interested individuals will be evaluated during a screening period
- 240 views
- 23 Nov, 2020
- 7 locations
The effect of daily intake of two different doses of Bifidobacterium Breve Bif195 on small-intestinal damage induced by Acetlysalicylic Acid- a randomized, double-blind, placebo-controlled, three-armed, parallel group trial in healthy volunteers.
used in the treatment of many common pain-related conditions, including headaches and menstrual pain, and for long-term treatment of chronic inflammatory diseases, including osteoarthritis and rheumatoid
- 848 views
- 23 Nov, 2020
- 1 location
Healthy NO 0009-0431 SAD
approximately 71 to 134 days (depending upon dose) plus a screening period of 2 to 28 days. You will need to attend:
- 1987 views
- 23 Nov, 2020
- 1 location
An early Feasibility Study to Evaluate the Safety and Functionality of an Individual Accruing Data Algorithm with LY3209590 in Adult Participants with Type 2 Diabetes
Objective: A multi-center, open label parallel device feasible study with two sequential study cohort in adult participates with Type 2 Diabetes Mellitus (T2D) who are currently treated with basal insulin or are insulin naïve.
- 0 views
- 28 Sep, 2022
- 1 location
Idiopathic Hypersomnia Clinical Research Trial
A Phase II, Placebo Controlled Double-blind randomized withdrawal study to Determine the Safety and Efficacy of Oral SDX in Patients with Idiopathic Hypersomnia (IH)Are you suffering from excessive daytime sleepiness due to Idiopathic Hypersomnia? We are currently investigating the wake promoting effects of an experimental drug that has been extensively …
- 0 views
- 06 Feb, 2023
- 1 location
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
- 82 views
- 23 Nov, 2020
- 1 location
Eosinophilic Esophagitis Research Study
The purpose of this study is to see if CC-93538 is safe and effective as a possible treatment for EoE. To do this, a comparison will be made between subjects who receive CC-93538 and subjects who receive a placebo (a ‘dummy treatment’ that looks like CC-93538 but contains no active …
- 0 views
- 14 Jan, 2022
- 1 location
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, 52-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF SIMUFILAM 100 MG TABLETS IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE
Simufilam is an experimental treatment, meaning that it has not yet been approved by the United States (US) Food and Drug Administration (FDA). In this study, the study medicine will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not …
- 3 views
- 25 Mar, 2022
- 1 location